Haemocompatibility improvement of metallic surfaces by covalent immobilization of heparin-liposomes

International Journal of Pharmaceutics

Volumn 432, Issue 1-2, 2012, Pages 91-98

  Kastellorizios, Michail ^a   Michanetzis, Georgios P A K ^b   Pistillo, Bianca Rita ^c   Mourtas, Spyridon ^a   Klepetsanis, Pavlos ^a,d   Favia, Piero ^c   Sardella, Eloisa ^c   D'Agostino, Ricardo ^c   Missirlis, Yannis F ^b   Antimisiaris, Sophia G ^a,d  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF BARI   (Italy)

^d INSTITUTE OF COMPUTER SCIENCE   (Greece)

Author keywords

Controlled drug release; Drug delivery; Haemocompatibility; Heparin; Liposomes; Plasma processing; Stent

Indexed keywords

1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOCHOLINE; CHOLESTEROL; HEPARIN; LIPOSOME; MACROGOL 2000; NANOMATERIAL; PHOSPHATIDYLCHOLINE; STAINLESS STEEL; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING TIME; BLOOD COMPATIBILITY; CONFOCAL LASER MICROSCOPY; COVALENT BOND; DRUG ELUTING STENT; DRUG RELEASE; ENCAPSULATION; LIPID COMPOSITION; PARTICLE SIZE; PLASMA; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE CHARGE; THROMBOCYTE ADHESION;

ANTICOAGULANTS; CHOLESTEROL; HEPARIN; HUMANS; LIPOSOMES; METALS; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PLASMA; PLATELET ADHESIVENESS; POLYETHYLENE GLYCOLS; STAINLESS STEEL;

EID: 84861626008     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.04.057     Document Type: Article

References (36)

1. S.G. Antimisiaris Preparation of DRV liposomes Meth. Mol. Biol. 605 2010 51 75
2. S.G. Antimisiaris Nanosized liposomes in drug delivery H.S. Nalwa, Encyclopedia of Nanoscience and Nanotechnology vol. 18 2011 American Scientific Publishers 455 487
3. S.G. Antimisiaris, G. Koromila, G. Michanetzis, and Y.F. Missirlis Liposome coated stents: a method to deliver drugs to the site of action and improve stent blood-compatibility J. Liposome Res. 16 2006 303 309
4. S.G. Antimisiaris, D. Siablis, E. Liatsikos, C. Kalogeropoulou, V. Tsotas, E. Tsota, and G. Barbalias Preparation and in vitro evaluation of liposome covered stents for use as ureteral stents J. Endourol. 14 2000 743 747
5. A.A. Bavry, and D.L. Bhatt Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis Lancet 371 2008 2134 2143
6. D.A. Brown, E.W. Lee, C.T. Loh, and S.T. Kee A new wave in treatment of vascular occlusive disease: biodegradable stents - clinical experience and scientific principles J. Vasc. Interv. Radiol. 20 2009 315 324
7. R. D'Agostino, P. Favia, C. Oehr, and M.P. Wertheimer Low temperature plasma processing of materials: past, present and future Plasma Proc. Polym. 2 2005 7 15
8. L. Detomaso, R. Gristina, R. d'Agostino, G.S. Senesi, and P. Favia Plasma deposited acrylic acid coatings: surface characterization and attachment of 3T3 murine fibroblast cell lines Surf. Coat. Technol. 200 2005 1022 1025
9. L. Detomaso, R. Gristina, G.S. Senesi, R. D'Agostino, and P. Favia Stable plasma-deposited acrylic acid surfaces for cell culture applications Biomaterials 26 2005 3831 3841
10. A.H. Gershlick Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials Atherosclerosis 160 2002 259 271
11. T. Hanawa Materials for metallic stents J. Artif. Organs 12 2009 73 79
12. Y. Huang, S.S. Venkatraman, F.Y. Boey, E.M. Lahti, P.R. Umashankar, M. Mohanty, S. Arumugam, L. Khanolkar, and S. Vaishnav In vitro and in vivo performance of a dual drug-eluting stent (DDES) Biomaterials 31 2010 4382 4391
13. Y. Huang, S.S. Venkatraman, F.Y. Boey, P.R. Umashankar, M. Mohanty, and S. Arumugam The short-term effect on restenosis and thrombosis of a cobaltchromium stent eluting two drugs in a porcine coronary artery model J. Interv. Cardiol. 22 2009 466 478
14. P. Kallinteri, S.G. Antimisiaris, I. Tsota, C. Kalogeropoulou, D. Karnabatidis, and D. Siablis Dexamethasone incorporating liposomes: an in vitro study of their applicability as a slow release delivery system of dexamethasone from covered metallic stents Biomaterials 23 2002 4819 4826
15. G. Kedia, and M.S. Lee Stent thrombosis with drug-eluting stents: a reexamination of the evidence Catheter Cardiovasc. Interv. 69 2007 782 789
16. K.L. Kennedy, A.R. Lucas, and W. Wan Local delivery of therapeutics for percutaneous coronary intervention Curr. Drug Deliv. 8 2011 534 556
17. A. Kivela, and J. Hartikainen Restenosis related to percutaneous coronary intervention has been solved? Ann. Med. 38 2006 173 187
18. G. Koromila, G. Michanetzis, Y.F. Missirlis, and S.G. Antimisiaris Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: effect on haemocompatibility Biomaterials 27 2006 2525 2533
19. A. Kraitzer, Y. Kloog, and M. Zilberman Approaches for prevention of restenosis J. Biomed. Mater. Res. Part B 85 2008 583 603
20. Y.K. Lee, J. Hyung-Park, H. Tae-Moon, D. Yun-Lee, J. Han-Yun, and Y. Byun The short term effects on restenosis and thrombosis of echinomycin-eluting stents top coated with a hydrophobic heparin-containing polymer Biomaterials 28 2007 1523 1530
21. E.N. Liatsikos, D. Karnabatidis, G.C. Kagadis, P.F. Katsakiori, J-U. Stolzenburg, G.C. Nikiforidis, P. Perimenis, and D. Siablis Metal stents in the urinary tract EAU-EBU Update Series 5 2007 77 88
22. R. Mehran, E.D. Aymong, D.T. Ashby, T. Fischell, H. Whitworth Jr., R. Siegel, W. Thomas, S.C. Wong, R. Narasimaiah, A.J. Lansky, and M.B. Leon Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an antithrombotic regimen of aspirin alone) study Circulation 108 2003 1078 1083
23. S. Moon, S.-G. Yang, and K. Na An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis Biomaterials 32 2011 3603 3610
24. S. Mourtas, M. Kastellorizios, P. Klepetsanis, E. Farsari, E. Amanatides, D. Mataras, B.R. Pistillo, P. Favia, E. Sardella, R. d'Agostino, and S.G. Antimisiaris Covalent immobilization of liposomes on plasma functionalized metallic surfaces Colloids Surf. B: Biointerfaces 84 2011 214 220
25. A.T.L. Ong, A. Hoye, J. Aoki, C.A. Van Mieghem, G.A. Rodriguez Granillo, K. Sonnenschein, E. Regar, E.P. McFadden, G. Sianos, W.J. van der Giessen, P.P. de Jaegere, P. de Feyter, R.T. van Domburg, and P.W. Serruys Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation J. Am. Coll. Cardiol. 45 2005 947 953
26. F. Palumbo, P. Favia, A. Rinaldi, M. Vulpio, and R. d'Agostino PE-CVD of organic thin films with controlled surface concentration of carboxylic groups Plasmas Polym. 4 1999 133 145
27. L. Pendyala, R. Jabara, T. Shinke, N. Chronos, K. Robinson, and J. Li Drug-eluting stents: present and future Cardiovasc. Hematol. Agents Med. Chem. 6 2008 105 115
28. B.R. Pistillo, L. Detomaso, E. Sardella, P. Favia, and R. d'Agostino RF-plasma deposition and surface characterization of stable (COOH)-rich thin films from cyclic l-lactide Plasma Proc. Polym. 4 S1 2007 S817 S820
29. L. Raber, and S. Windecker Current status of drug-eluting stents Cardiovasc. Ther. 29 2011 176 189
30. G.M. Richter, J.C. Palmaz, G. Noeldge, and F. Tio Relationship between blood flow, thrombus, and neointima in stents J. Vasc. Interv. Radiol. 10 1999 598 604
31. N.P. Rhodes, and D.F. Williams Plasma recalcification as a measure of contact phase activation and heparinization efficacy after contact with biomaterials Biomaterials 15 1994 35 37
32. J.C.M. Stewart Colorimetric determination of phospholipids with ammonium ferrothiocyanate Anal. Biochem. 104 1980 10 14
33. S. Tsimikas Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited J. Am. Coll. Cardiol. 47 2006 2112 2115
34. V-A. Tsotas, S. Mourtas, and S.G. Antimisiaris Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability Drug Deliv. 14 2007 441 445
35. S. Venkatraman, and F. Boey Release profiles in drug-eluting stents: issues and uncertainties J. Control. Release 120 2007 149 160
36. D.M. Whelan, W.J. Van Der Giessen, S.C. Krabbendam, E.A. Van Vliet, P.D. Verdouw, P.W. Serruys, and H.M.M. Van Beusekom Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries Heart 83 2000 338 345